OXPENTIFYLLINE IN ENDOTOXAEMIA
- 1 December 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 334 (8678-8679) , 1474-1477
- https://doi.org/10.1016/s0140-6736(89)92929-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- PENTOXIFYLLINE INHIBITS GRANULOCYTE AND PLATELET-FUNCTION, INCLUDING GRANULOCYTE PRIMING BY PLATELET ACTIVATING FACTOR1988
- Attenuation of Acute Lung Injury in Septic Guinea Pigs by PentoxifyllineAmerican Review of Respiratory Disease, 1988
- Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifyllineInfection and Immunity, 1988
- Tumor Necrosis Factor Causes Increased Pulmonary Permeability and Edema: Comparison to Septic Acute Lung InjuryAmerican Review of Respiratory Disease, 1988
- Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-AlphaJournal of Leukocyte Biology, 1987
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- Effect of Pentoxifylline on the Phagocytic Activity, cAMP Levels, and Superoxide Anion Production by Monocytes and Polymorphonuclear CellsJournal of Leukocyte Biology, 1986
- Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.Proceedings of the National Academy of Sciences, 1985
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982